PARAMETRIC PORTFOLIO ASSOCIATES LLC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 103 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$67,000
-94.3%
52,004
-94.4%
0.00%
-100.0%
Q4 2021$1,174,000
+19.2%
924,598
+104.5%
0.00%0.0%
Q3 2021$985,000
-74.1%
452,048
-55.4%
0.00%
-50.0%
Q2 2021$3,802,000
+66.9%
1,013,820
+45.1%
0.00%
+100.0%
Q1 2021$2,278,000
-12.1%
698,720
-8.1%
0.00%
-50.0%
Q4 2020$2,592,000
-17.8%
760,091
-1.7%
0.00%0.0%
Q3 2020$3,155,000
+57.5%
773,242
+30.5%
0.00%0.0%
Q2 2020$2,003,000
+309.6%
592,717
+182.5%
0.00%
Q1 2020$489,000
-15.1%
209,845
+32.7%
0.00%
Q4 2019$576,000
-57.5%
158,160
-3.1%
0.00%
-100.0%
Q3 2019$1,354,000
+7.6%
163,284
+11.8%
0.00%0.0%
Q2 2019$1,258,000
-2.5%
146,075
+21.1%
0.00%0.0%
Q1 2019$1,290,000
+26.0%
120,645
+3.1%
0.00%0.0%
Q4 2018$1,024,000
-51.9%
117,006
-7.8%
0.00%
-50.0%
Q3 2018$2,131,000
-26.6%
126,870
-8.4%
0.00%
-33.3%
Q2 2018$2,904,000
+40.7%
138,542
+8.0%
0.00%
+50.0%
Q1 2018$2,064,000
-28.2%
128,264
-15.4%
0.00%
-33.3%
Q4 2017$2,873,000
+80.6%
151,592
+34.1%
0.00%
+50.0%
Q3 2017$1,591,000
+105.6%
113,049
+8.8%
0.00%
+100.0%
Q2 2017$774,000
-9.8%
103,935
-21.3%
0.00%0.0%
Q1 2017$858,000
+70.9%
132,064
+16.6%
0.00%0.0%
Q4 2016$502,000
-34.1%
113,304
-30.5%
0.00%0.0%
Q3 2016$762,000
-29.6%
163,135
-1.0%
0.00%
-50.0%
Q2 2016$1,082,000
-2.7%
164,703
-5.8%
0.00%0.0%
Q1 2016$1,112,000
+33.2%
174,823
+26.2%
0.00%
+100.0%
Q4 2015$835,000
+30.7%
138,547
+29.6%
0.00%0.0%
Q3 2015$639,000
+3.6%
106,868
+18.4%
0.00%0.0%
Q2 2015$617,000
+158.2%
90,248
+129.4%
0.00%
Q1 2015$239,000
-39.8%
39,348
-31.3%
0.00%
-100.0%
Q4 2014$397,000
-4.1%
57,267
+12.6%
0.00%0.0%
Q3 2014$414,000
+4.3%
50,866
+4.2%
0.00%0.0%
Q2 2014$397,000
+162.9%
48,816
+153.6%
0.00%
Q1 2014$151,000
-5.6%
19,248
+6.8%
0.00%
Q4 2013$160,0000.0%18,027
-5.9%
0.00%
Q3 2013$160,000
+20.3%
19,150
+7.0%
0.00%
Q2 2013$133,00017,8920.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders